End­points ed­i­tors se­lect the top trends of 2022: M&A looks hot as IPOs wane, it's time to see some hard da­ta on AI and can ac­cel­er­at­ed ap­proval re­main in­tact?

It’s time for our hol­i­day break here at End­points News, and like a lot of you, we’ve been prep­ping for 2022.

Any­one who’s spent some time in in­dus­try can tell you the past decade has shoved the drug-hunt­ing field in­to the fore­front of the world’s view of things, gar­ner­ing tens of bil­lions in in­vest­ment as new tech­nolo­gies look to change the land­scape of R&D. And any­one who qual­i­fies for first-in-class and best-in-class can clean up.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN